Source: Annual Congress 2006 - Asthma - miscellaneous issues
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
M. N. Akulova, S. I. Ovcharenko, E. N. Ischenko (Moscow, Russian Federation). Evaluation of adherence of patients with asthma to treatment by single combination inhaler. Eur Respir J 2006; 28: Suppl. 50, 2884

Member's Comments

No comment yet.

Related content which might interest you: Influence of treatment by single combined inhaler on adherence of patients with asthma Source: Annual Congress 2009 - Respiratory physiology Year: 2009 Novel combination inhaler for mild asthma treatment Source: Annual Congress 2008 - Asthma control or asthma severity Year: 2008 Asthma patients‘ preferences for single inhaler therapy Source: Eur Respir J 2004; 24: Suppl. 48, 285s Year: 2004 Improved and maintained asthma control with once-daily budesonide/formoterol single inhaler therapy in mild-to-moderate persistent asthma Source: Eur Respir J 2001; 18: Suppl. 33, 21s Year: 2001 The asthmatic patient and inhaler treatment devices profile in Turkey: Asthma inhaler treatment study Source: Annual Congress 2012 - Treatment of asthma, bronchiectasis and cough: inhaler use Year: 2012 Improvement in health status in patients with moderate to severe COPD after treatment with budesonide/formoterol in a single inhaler Source: Eur Respir J 2002; 20: Suppl. 38, 250s Year: 2002 Adherence with two types of inhaled corticosteroids as a primary controller regimen in adult asthma patients Source: Eur Respir J 2002; 20: Suppl. 38, 304s Year: 2002 Cost-effectiveness of a single inhaler triple therapy versus ICS/LABA in COPD Source: International Congress 2018 – COPD, asthma and tuberculosis: benefits related to therapy costs Year: 2018 Cost-effectiveness of budesonid/formoterol inhaler in treatment of moderate bronchial asthma Source: Eur Respir J 2006; 28: Suppl. 50, 499s Year: 2006 Treatment patterns in English asthma patients initiating multiple inhaler triple therapy: a cohort study Source: Virtual Congress 2020 – Asthma and cough: clinical trials and pharmacological insights Year: 2020 Efficacy of a combination therapy with single inhaler budesonide/formoterol in the treatment of acute exacerbations of COPD (AECOPD) Source: Eur Respir J 2004; 24: Suppl. 48, 252s Year: 2004 Feedback on inhaler use does not significantly improve inhaled corticosteroid adherence or clinical outcomes Source: Virtual Congress 2020 – Digital technologies in airway diseases Year: 2020 High dose inhaler corticosteroids in patients with COPD Source: Eur Respir J 2004; 24: Suppl. 48, 289s Year: 2004 Add-on LABA in a separate inhaler as asthma step-up therapy versus increased dose of ICS or ICS/LABA combination inhaler Source: ERJ Open Res 2016: 00106-2015 Year: 2016 Comparative safety-efficacy trial using three inhaler combinations in moderate persistent asthma Source: Annual Congress 2010 - Aspects of severe asthma Year: 2010 Scientific rationale for using a single inhaler for asthma control by comparison of the effectiveness and safety of formoterol/budesonide turbuhaler as physician-guided adjustable maintenance dosing regimen versus formoterol/budesonide given as fixed dose of twice daily therapy in the management of bronchial asthma Source: Annual Congress 2009 - Aspects of clinical asthma Year: 2009 The effect of inhaler switching on asthma and COPD patients Source: International Congress 2018 – Respiratory epidemiology: from COPD to factors that associate with lung function and infections Year: 2018 Comparative effectiveness of two different doses of inhaled corticosteroid in triple therapy on exacerbations in patients with severe COPD: a real-world study Source: Virtual Congress 2021 – Therapies for respiratory diseases in primary care and COVID - 19 Year: 2021 Cost-effectiveness of fluticasone/salmeterol inhaler in treatment of moderate and severe bronchial asthma Source: Annual Congress 2008 - Comorbid cardiovascular condition and therapy of asthma Year: 2008 Are COPD patients taking triple combination inhalers being overmedicated during acute exacerbations? Source: International Congress 2019 – COPD treatment: cohorts and real-world studies Year: 2019